Euroopan unioni - englanti - EMA (European Medicines Agency)

merck sharp & dohme b.v. - rotavirus serotype g1, serotype g2, serotype g3, serotype g4, serotype p1 - immunization; rotavirus infections - vaccines, viral vaccines - rotateq is indicated for the active immunisation of infants from the age of six weeks to 32 weeks for prevention of gastroenteritis due to rotavirus infection.rotateq is to be used on the basis of official recommendations.

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - bovine rotavirus (ncdv); clostridium perfringens type c toxoid; escherichia coli k99 pilus antigens; clostridium perfringens type d toxoid; bovine coronavirus (inactivated) - misc. vaccines or anti sera - bovine rotavirus (ncdv) biological-virus active 1.0 rp; clostridium perfringens type c toxoid vaccine-toxoid active 10.0 iu/ml; escherichia coli k99 pilus antigens vaccine-microbial active 1.0 rp; clostridium perfringens type d toxoid vaccine-toxoid active 2.0 iu/ml; bovine coronavirus (inactivated) vaccine-viral active 1.0 rp - immunotherapy - cow | healthy pregnant heifer | bovine | female cattle - bovine rotaviruses | neonatal calf diarrhea | neonatal enterotoxemia | raise colostral antibodies | against bovine rotavirus and | coronavirus | enterotoxigenic e.coli pilus | g6 and g10 | type k99

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - inactivated bovine pestivirus - bega strain; inactivated bovine pestivirus - trangie strain; thiomersal - misc. vaccines or anti sera - inactivated bovine pestivirus - bega strain vaccine-viral active 0.0 p; inactivated bovine pestivirus - trangie strain vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - bovine pestivirus

Australia - englanti - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - japanese encephalitis virus, quantity: 6 agu - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; sodium chloride; monobasic potassium phosphate; dibasic sodium phosphate; water for injections - jespect is indicated for active immunisation against japanese encephalitis (je) virus for persons 18 years of age and older. jespect should be considered for use in persons who plan to reside in or travel to areas where je is endemic (common) or epidemic (seasonal), especially during the transmission season. jespect is indicated for persons who work with je virus in laboratories and in industry.

Australia - englanti - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rotavirus, quantity: 1000000 ccid50/dose - oral liquid, suspension - excipient ingredients: sucrose; water for injections; adipic acid; sodium hydroxide; glucose monohydrate; sodium chloride; potassium chloride; magnesium sulfate heptahydrate; ferric nitrate nonahydrate; dibasic sodium phosphate dihydrate; sodium pyruvate; folic acid; calcium pantothenate; inositol; choline chloride; nicotinamide; pyridoxine hydrochloride; thiamine hydrochloride; riboflavine; cystine; tyrosine; arginine; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; threonine; tryptophan; serine; valine; glutamine; calcium chloride dihydrate; sodium bicarbonate - rotarix is indicated for the prevention of rotavirus gastroenteritis (see clinical trials).

Australia - englanti - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - rotavirus, quantity: 1000000 ccid50/dose - oral liquid, suspension - excipient ingredients: sucrose; water for injections; adipic acid; sodium hydroxide; glucose monohydrate; sodium chloride; potassium chloride; magnesium sulfate heptahydrate; ferric nitrate nonahydrate; dibasic sodium phosphate dihydrate; sodium pyruvate; folic acid; calcium pantothenate; inositol; choline chloride; nicotinamide; pyridoxine hydrochloride; thiamine hydrochloride; riboflavine; cystine; tyrosine; arginine; glycine; histidine; isoleucine; leucine; lysine; methionine; phenylalanine; threonine; tryptophan; serine; valine; glutamine; calcium chloride dihydrate; sodium bicarbonate - rotarix is indicated for the prevention of rotavirus gastroenteritis (see clinical trials).

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bovine rotavirus g10; bovine rotavirus g6; e. coli strain - o64:k99; bovine coronavirus (inactivated); gentamicin; formaldehyde; thiomersal - misc. vaccines or anti sera - bovine rotavirus g10 active 1.0 rp/2ml d; bovine rotavirus g6 active 1.3 rp/2ml d; e. coli strain - o64:k99 vaccine-microbial active 1.0 rp/2ml d; bovine coronavirus (inactivated) vaccine-viral active 1.0 rp/2ml d; gentamicin antibiotic other 30.0 ug/ml; formaldehyde aldehyde other 0.74 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - cow - pregnant | healthy pregnant heifer | bovine | pregnant cow - neonatal calf diarrhea

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bovine viral diarrhoea virus bega strain - unknown - bovine viral diarrhoea virus bega strain vaccine-viral active 0.0 - active constituent

Australia - englanti - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bovine viral diarrhoea virus trangie strain - unknown - bovine viral diarrhoea virus trangie strain biological-virus active 0.0 - active constituent

Yhdysvallat - englanti - NLM (National Library of Medicine)

leadiant biosciences, inc. - pegademase bovine (unii: hw3h7d91f6) (pegademase bovine - unii:hw3h7d91f6) - pegademase bovine 250 [iu] in 1 ml - adagen® (pegademase bovine) injection is indicated for enzyme replacement therapy for adenosine deaminase (ada) deficiency in patients with severe combined immunodeficiency disease (scid) who are not suitable candidates for – or who have failed – bone marrow transplantation. adagen® (pegademase bovine) injection is recommended for use in infants from birth or in children of any age at the time of diagnosis. adagen® (pegademase bovine) injection is not intended as a replacement for hla identical bone marrow transplant therapy. adagen® (pegademase bovine) injection is also not intended to replace continued close medical supervision and the initiation of appropriate diagnostic tests and therapy (e.g., antibiotics, nutrition, oxygen, gammaglobulin) as indicated for intercurrent illnesses. there is no evidence to support the safety and efficacy of adagen® (pegademase bovine) injection as preparatory or support therapy for bone marrow transplantation. since adagen® (pegademase bovine) injection is admin